A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression

Journal of Clinical Psychiatry

Volumn 60, Issue 2, 1999, Pages 79-88

  Calabrese, Joseph R ^a,c   Bowden, Charles L ^c   Sachs, Gary S ^c   Ascher, John A ^b   Monaghan, Eileen ^b   David Rudd, G ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b GLAXOSMITHKLINE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; LAMOTRIGINE;

ARTICLE; BIPOLAR DEPRESSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; PAIN; PRIORITY JOURNAL; RASH; RATING SCALE; TREATMENT OUTCOME; VERTIGO; XEROSTOMIA;

EID: 0033004838     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v60n0203     Document Type: Article

References (48)

1. Calabrese JR, Bowden CL, Woyshville MJ. Lithium and the anticonvulsants in the treatment of bipolar disorder. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press: 1995:1099-1111
2. Post RM, Denicoff KD, Leverich G, et al. Drug-induced switching in bipolar disorder: epidemiology and therapeutic implications. CNS Drugs 1997;8:352-365
3. Smith D, Chadwick D, Baker G, et al. Seizure severity and the quality of life. Epilepsia 1993;34(suppl 5):S31-S35
4. Weisler RH, Risner ME, Ascher JA, et al. Use of lamotrigine in the treatment of bipolar disorder. In: New Research Program and Abstracts of the 147th Annual Meeting of the American Psychiatric Association; May 26, 1994; Philadelphia, Pa. Abstract 611:216
5. Calabrese JR, Fatemi SH, Woyshville MJ. Antidepressant effects of lamotrigine in rapid cycling bipolar disorder [letter]. Am J Psychiatry 1996; 153:1236
6. Walden J, Hesslinger B, van Calker D, et al. Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder. Pharmacopsychiatry 1996;29:193-195
7. Berlant JL. ADHD and bipolar disorder as predictors of clinical response to lamotrigine. In: Abstracts of the 2nd International Conference on Bipolar Disorder; June 19, 1997; Pittsburgh, Pa. Abstract 7
8. Berlant JL. Case report of synergistic response of rapid cycling bipolar disorder to lamotrigine, risperidone, and verapamil. In: Abstracts of the 2nd International Conference on Bipolar Disorder; June 19, 1997; Pittsburgh, Pa. Abstract 8
9. Hoopes S, Snow M. Clinical effectiveness of lamotrigine in affective disorders. In: Abstracts of the 2nd International Conference on Bipolar Disorder; June 19, 1997; Pittsburgh, Pa. Abstract 26
10. Fatemi SH, Rapport DJ, Calabrese JR, et al. Lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry 1997;58:522-527
11. Ferner IN, Potkins D, Eccleston D. Lamotrigine treatment in rapid cycling bipolar disorder (BPD): clinical and biological correlates. In: Abstracts of the 2nd International Conference on Bipolar Disorder; June 19, 1997; Pittsburgh, Pa. Abstract 15
12. Fogelson DL, Sternbach H. Lamotrigine treatment of refractory bipolar disorder [letter]. J Clin Psychiatry 1997;58:271-273
13. Kusumakar V, Yatham LN. Lamotrigine treatment of rapid cycling bipolar disorder. Am J Psychiatry 1997;154:1171-1172
14. Kusumakar V, Yatham LN. An open study of lamotrigine in refractory bipolar depression. Psychiatry Res 1997;72:145-148
15. Mandoki M. Lamotriginc/valproate in treatment resistant bipolar disorder in children and adolescents. In: Society for Biological Psychiatry, 52nd Annual Convention & Scientific Program; May 1997; San Diego, Calif. Abstract 321
16. Mauri MC, Laini V, Somaschini E, et al. Lamotrigine: an alternative drug in the prophylaxis of bipolar disorder [abstract]. Eur Neuropsychopharmacol 1997;6:S161
17. Sporn J, Sachs GS. The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. J Clin Psychopharmacol 1997;17:185-189
18. Corn T, Ascher J, Calabrese J, et al. Lamictal in the treatment of bipolar disorder. In: Scientific Abstracts of the 35th Annual Meeting of the American College of Neuropsychopharmacology; December 11-15, 1995; San Juan, Puerto Rico; 222
19. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
20. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296
21. First MB, Spitzer RI, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). New York, NY: New York: Biometric Research, New York State Psychiatric Institute; 1996
22. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389
23. Endicott J, Spitzer RL. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1978;35:837-848
24. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
25. Fieve RR, Platman SR, Plutchik RR. The use of lithium in affective disorders, I: acute endogenous depression. Am J Psychiatry 1968;125:487-491
26. Goodwin FK, Murphy DL, Bunney WE. Lithium-carbonate treatment in depression and mania: a longitudinal double-blind study. Arch Gen Psychiatry 1969;21:486-496
27. Greenspan K, Schildkraut JJ, Gordon EK, et al. Catecholamine metabolism in affective disorders. III: MHPG and other catecholamine metabolites in patients treated with lithium carbonate. J Psychiatr Res 1970;7: 171-183
28. Stokes PE, Stoll PM, Shamoian CA, et al. Efficacy of lithium as acute treatment of manic depressive illness. Lancet 1971;26:1319-1325
29. Goodwin FK, Murphy DL, Dunner DL, et al. Lithium response in unipolar versus bipolar depression. Am J Psychiatry 1972;129:44-47
30. Noyes R, Dempsey GM, Blum A, et al. Lithium treatment of depression. Compr Psychiatry 1974;15:187-193
31. Baron M, Gershon ES, Rudy V, et al. Lithium carbonate response in depression. Arch Gen Psychiatry 1975;32:1107-1111
32. Mendels J. Lithium in the treatment of depression. Am J Psychiatry 1976;133:373-378
33. Donnelly EF, Goodwin FK, Waldan IN, et al. Prediction of antidepressant responses to lithium. Am J Psychiatry 1978;135:552-556
34. Post RM, Uhde TW, Roy-Byrne PP, et al. Antidepressant effects of carbamazepine. Am J Psychiatry 1986;143:29-34
35. Kessel A, Holt NF. A controlled study of a tetracyclic antidepressant-maprotiline (Ludiomil). Med J Aust 1975;1:773-776
36. Watanabe S, Ishino H, Otsuki S. Double-blind comparison of lithium carbonate and imipramine in treatment of depression. Arch Gen Psychiatry 1975;32:659-668
37. Cohn JB, Collins G, Ashbrook E, et al. A comparison of fluoxetine, imipramine, and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol 1989;4:313-322
38. Baumhackl U, Biziere K, Fischbach R, et al. Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study. Br J Psychiatry 1989;155(6, suppl):78-83
39. Himmelhoch JM, Thase ME, Mallinger AG, et al. Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 1991;148: 910-916
40. Sachs GS, Lafer B, Stoll AL, et al. A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry 1994;55:391-393
41. Silverstone T. A double-blind multicentre trial of moclobemide vs imipramine in bipolar depression. Eur Neuropsychopharmacol 1997;7(suppl 2): S169-S170
42. Young ML, Pitts CD, Oakes R, et al. A double-blind, placebo-controlled trial comparing the effect of paroxetine and imipramine in the treatment of bipolar depression. In: Abstracts of the 2nd International Conference on Bipolar Disorder; June 19, 1997; Pittsburgh, Pa. Abstract 66
43. Faedda GL, Tondo L, Baldessarini RJ, et al. Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders. Arch Gen Psychiatry 1993;50:448-455
44. Lydiard RB, Stahl SM, Hertzman M, et al. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression. J Clin Psychiatry 1997;58:484-491
45. Thase ME, for the Venlafaxine XR 209 Study Group. Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression. J Clin Psychiatry 1997;58:393-398
46. Matsuo F, Bergen D, Faught E, et al. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. Neurology 1993;43:2284-2291
47. Messenheimer J, Mullens EL, Giorgi L, et al. Safety review of adult clinical trial experience with lamotrigine. Drug Saf 1998;18:281-296
48. Lamotrigine (Lamictal). Physicians' Desk Reference. Montvale, NJ: Medical Economics; 1998:1043-1048